Skin Necrosis and Purpura Fulminans in Children With and Without Thrombophilia--A Tertiary Center's Experience.

about

Skin Necrosis and Purpura Fulminans in Children With and Without Thrombophilia--A Tertiary Center's Experience.

Item

http://www.wikidata.org/entity/Q45879731

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Skin Necrosis and Purpura Fulm ...... Tertiary Center's Experience.

@en

Skin Necrosis and Purpura Fulm ...... Tertiary Center's Experience.

@nl

type

Item

label

Skin Necrosis and Purpura Fulm ...... Tertiary Center's Experience.

@en

Skin Necrosis and Purpura Fulm ...... Tertiary Center's Experience.

@nl

prefLabel

Skin Necrosis and Purpura Fulm ...... Tertiary Center's Experience.

@en

Skin Necrosis and Purpura Fulm ...... Tertiary Center's Experience.

@nl

P1476

Skin Necrosis and Purpura Fulm ...... Tertiary Center's Experience.

@en

P2093

Gideon Paret

http://www.w3.org/2001/XMLSchema#string

Gili Kenet

http://www.w3.org/2001/XMLSchema#string

Joseph Kapelushmik

http://www.w3.org/2001/XMLSchema#string

Marina Rubinstein

http://www.w3.org/2001/XMLSchema#string

Miriam Ben Harush

http://www.w3.org/2001/XMLSchema#string

Shoshana Revel-Vilk

http://www.w3.org/2001/XMLSchema#string

Tzipora Strauss

http://www.w3.org/2001/XMLSchema#string

Yariv Fruchtman

http://www.w3.org/2001/XMLSchema#string

P2860

Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency

Purpura fulminans: recognition, diagnosis and management

Protein C deficiency

Efficacy and safety of recombinant human activated protein C for severe sepsis

Regulation of the protein C anticoagulant and antiinflammatory pathways.

Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients

Protein C deficiency in a family with thromboembolism and identified gene mutations.

Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C

Aspects of anticoagulation in children.

Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment.

P304

505-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08880018.2015.1068896

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282673174

http://www.w3.org/2001/XMLSchema#string

P698

26436558

http://www.w3.org/2001/XMLSchema#string

P921

thrombophilia